A trial of Moderna’s norovirus vaccine in the U.S. has been put on hold by the FDA over a reported case of neurological ...

The FDA paused Moderna's norovirus vaccine trial due to a neurological side effect. New U.S. health secretary Robert F.

The CDC learned of the decision Monday morning via a verbal notice. “I am actually somebody who got Guillain-Barré Syndrome ...

Moderna's norovirus vaccine trial paused due to a rare neurological effect, Citadel's short position in GSK, bird flu response issues during Trump's term, WHO's call for alcohol warning labels, and ...

This is significantly more than the equivalent for the flu vaccine, which generates one to two cases of Guillain-Barré syndrome per million vaccine doses. However, the FDA added that the new ...

Get the latest on crucial health initiatives, research breakthroughs, and policy changes impacting public health and ...